abstract |
The invention relates to variant CD44 surface proteins. Antibodies against the variant determinant of these proteins and a process for producing them, and in addition the C-DNA sequences which code for these variant protein pieces, and the use of these proteins or parts thereof and the antibodies directed against them for the diagnosis and treatment of tumor metastases. |